|
인쇄하기
취소
|
KFDA to shorten screening period of biosimilar products
Published: 2010-06-17 06:59:00
Updated: 2010-06-17 06:59:00
The national health watchdog is considering shortening the license period of biosimilar products to facilitate its local development.
In addition to that, the government will also establish an integrated database of the country's biological resources, intending to improve the efficiency of information management, the Ministry of Education, Science and Technology said Wednesday.
The develo...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.